#ASH24 Just going to leave this here and viewers can draw their own conclusions 👏 In patients with high-risk smoldering MM (I think all enrolled AQUILA pts and not just 20/2/20), patient-reported QOL with monthly daratumumab versus active monitoring. Great to see! #MMsm

New 📄🚨on everyone's least favorite myeloid neoplasms:TP53m AML&MDS 🧵In short: 🔴pls don’t exclude these pts of allo-HSCT, their only chance at cure.   🔴TP53 burden is key 🔴Blasts matter (for real… not only b/c I’m a pathologist 🔬😉) haematologica.org/article/view/1…

Join PeerView at #ASCO25 for a powerhouse lineup of #oncology symposia covering #HCC, #NSCLC, #CRC, #MM, #AML, #gastriccancer & more. Don’t miss expert insights, cases & #CME credits—live in Chicago or virtually! Register now ⏩ bit.ly/Onc25T Proud to partner &

Proud to partner with PeerView on this live & virtual #CME event at #ASCO25 focused on the evolving role of immunotherapy across the NSCLC spectrum. Don’t miss it! 🗓️ May 30 | 7 PM CDT 🔗 bit.ly/2025NSCLCT #LungCancer #NSCLC #Immunotherapy

#ASCO25 is just 2⃣ weeks away! Don't miss PeerView & renowned #Oncology experts for in-depth discussions on #HCC, #NSCLC, #CRC, #MM, #AML, #GastricCancer & more. No matter if you’re attending in Chicago or online, we are eager to see you‼️ bit.ly/Onc25T #CME 🩺

Remember to join us Saturday, May 31, at 6:30 PM CDT/7:30 PM EDT, for our #ProstateCancer live in-person & virtual symposium. Please submit your questions in advance and follow PeerView for more #MedEd content! bit.ly/25ProstateT #ASCO25 Elena Castro

Friendly reminder 📌 Just a few days away! PeerView HealthTree Foundation AML session.

Modern #HCC care is evolving—are you keeping up? Join PeerView & Blue Faery at #ASCO25 to hear experts break down the latest in systemic therapy, personalized plans & more. 🗓️ May 31 | 7 PM CDT 🔗 vist.ly/3n5j9pn #Oncology #CancerTreatment

Check out today’s lineup! From #AML to #NSCLC, our PeerView sessions bring together leading experts and fresh insights you can bring back to your practice. 🔗 bit.ly/Onc25T Komal Jhaveri, MD, FACP, FASCO Javier Cortes MD PhD Daniel Ahn Sagar Lonial MD Hans Lee Krina Patel

#ASCO25 offering some key data in #NSCLC including in #neoadjuvant & @perioperative settings - grateful for insights from Drs Tina Cascone (MD Anderson Cancer Center) bet9 优德体育 足球 速8体育 彩金 江山美景图 彩娱乐 AB视讯 Heather Wakelee & Adam J. Schoenfeld tonight (Fri, 6:30pm, Hyatt Regency Chicago)! #LCSM PeerView LUNGevity Foundation

Great cme panel tonight on #AML with Naval Daver, M.D. come join us at the Hyatt Regency peerview.com/2025AML PeerView

🎯 We’re ready for today’s #CRC session at #ASCO25. The room is set, the energy’s high, & we can’t wait to hear from the experts on #CRC care. 📍 Hyatt Regency Chicago, Regency Ballroom AB (Ballroom Level, West Tower)! ⏰6:30 PM | Don’t miss it! 🔗 bit.ly/Onc25T🚀

Thank you to Naval Daver, M.D., Jessica Altman, MD, and Dr. Alice Mims for leading an engaging PeerView x HealthTree Foundation #AML symposium at #ASCO25! If you missed the live session, stay tuned for the replay. bit.ly/AML-T

Conference essentials: coffee, comfortable shoes, and an eager mind for the latest in oncology. We’re geared up and ready to make the most of Day Two! #ASCO25 🔗 Save your spot: bit.ly/Onc25T

We’re thrilled to have you join us, Krina Patel! Looking forward to an engaging session on #multiplemyeloma and sharing the latest insights to improve outcomes for our patients. #ASCO25 Sagar Lonial MD Hans Lee

Join PeerView Krish Patel Nitin Jain Meghan Thompson tonight for a #CLL #CME session where your questions take center stage PeerView.com/2025CLL #ASCO25

Great PeerView panel tonight discussing 4 innovations in #myeloma from quads to CAR-T to BCMA antibodies & next-gen agents come join us! PeerView.com/2025MM Sagar Lonial MD #ASCO

🌟 That’s a wrap on two incredible nights of cutting-edge discussions at #ASCO25! Thanks to the PeerView ASCO 2025 class—faculty, attendees, staff & our amazing partners—for joining us in advancing oncology care. Stay tuned for replays if you missed out! #OncologyEducation

Ben Solomon Todd M. Bauer ✅ What would you recommend as the next step in the care of a 54-yo 👳‍♀️ with #mNSCLC 🫁, PD-L1 60%, but NGS pending? Ben Solomon, Todd M. Bauer, LUNGevity Foundation #LCSM #LungCancer

🎉Finally out🎉 Defining remission following hematopoietic cell transplant for myelofibrosis #mpnsm Leukemia Journal nature.com/articles/s4137…